NCT02902289View on ClinicalTrials.gov

Bioequivalence Study of Ibuprofen 200 mg/5 mL Oral Suspension vs. MOMENT 200 mg Coated Tablet

PHASE1CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Healthy

Interventions

DRUG

Ibuprofen 200 mg/5 mL oral suspension

DRUG

MOMENT 200 mg coated tablet

Trial Locations (1)

CH-6864

CROSS Research S.A., Phase I Unit, Arzo

Sponsors

Collaborators (1)

Cross Research S.A.

All Listed Sponsors

collaborator

Cross Research S.A.

INDUSTRY

lead

Aziende Chimiche Riunite Angelini Francesco S.p.A

INDUSTRY

NCT02902289 - Bioequivalence Study of Ibuprofen 200 mg/5 mL Oral Suspension vs. MOMENT 200 mg Coated Tablet | Biotech Hunter | Biotech Hunter